Durvalumab vs Lisinopril

## Durvalumab vs Lisinopril: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Lisinopril**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Lisinopril**: ACE inhibitor preventing conversion of angiotensin I to angiotensin II.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Lisinopril — 12 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Lisinopril — C21H31N3O5.

**Molecular Weight**: Durvalumab — N/A; Lisinopril — 405.4900 g/mol.

**Type**: Durvalumab — Antibody; Lisinopril — Small molecule.